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The Harderian glands are innervated by sympathetic fibers originating in the superior cervical ganglia. 
The aim of this study is to characterize the /3-adrenergic receptors in the rat Harderian gland. The 
characteristics of/3-adrenergic receptors were determined in crude membrane preparations from rat 
125 125 Harderian gland, using [ I]iodocyanopindolol ([ I]CYP) as radioligand. The binding of the ligand 
to the receptor is rapid, reversible, saturable, specific and dependent on time, temperature and 
membrane concentration. At 30~ stoichiometric data suggest the presence of one binding site with a 
K a value of 0.29 nM and Bmax of 32 pmol/L. The interaction shows a high degree of specificity for 
/3-adrenergic agonists and blockers, as suggested by competitive displacement experiments with 
isoproterenol (ICso = 19.1 nM), propranolol (ICso = 28.1 nM), and norepinephrine (ICso = 96.3 nM). 
Clonidine, yohimbine, methoxamine, and prazosin are ineffective at concentrations up to 1 IzM. In the 
other hand, binding of [125I]CYP by Harderian gland membranes exhibits day-night variations. 
Binding values are low during the daytime and increase progressively ate in the evening to reach a 
maximum at 2200 h (2 h after the onset of dark period), but decreased to the end of the dark period 
(0600 h). In conclusion, the results presented in this paper show the functional and pharmacological 
characterization f/3-adrenergic receptors in the rat Harderian gland. This neurotransmitter may play 
a physiological role at this level regulating, at least, processes such as a thyroid hormone metabolism. 
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INTRODUCTION 
Harderian glands were discovered by Harder in 1694, and are found in the medial 
and posterior area to the eyeball. The Harderian glands are large tubuloalveolar, 
possessing a nictating membrane (Davis, 1929). In the hamster, but not in the rat, 
Harderian glands exhibit marked sexual differences; the female type possesses a 
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single type of secretory cells (type I), while the male type gland exhibits two 
secretory cell types (type I and type II) which appear in similar percentage (50%) 
(Hoffman, 1971). Type II cells are exclusively present in the male hamster but 
disappear after androgen deprivation being replaced by type I cells that express 
melatonin receptors (Menendez-Pelaez et al., 1993). Characteristically, the 
Harderian glands of many species contain several indoleamines, melatonin 
(Menendez-Pelaez et al., 1989), and porphyrins (Margolis, 1971), showing marked 
sexual differences, with male levels being much lower than those of female. The 
castration can cause substantial changes in the porphyrin concentrations in the 
Harderian glands of the male hamster. Likewise, light deprivation for as short a 
period as 1 week by means of bilateral enucleation led to significant reduction in 
the porphyrin concentration i the Harderian glands of female hamsters ('Van 
Jaarsveld et al., 1989). 
In addition, several rhythms that may be related to the light:dark cycle have 
been described in the Harderian gland, such as melatonin content (Reiter et al., 
1983) and specific melatonin receptors (Lopez-Gonzalez et al., 1991; Calvo et al., 
1995). Harderian glands also contain the deiodinating enzyme, type II thyroxine 
5'deiodinase (Guerrero et al., 1987). Presumably, darkness induces increases in 
the enzyme activity by releasing norepinephrine from the postganglionic nerve 
endings that innervate the Harderian gland (Osuna et al., 1992). The Harderian 
glands are innervated by sympathetic fibers originating in the superior cervical 
ganglia (Huhtala et al., 1977). In rat and other mammalian species studied, 
Harderian glands not only contain adrenergic and cholinergic nerve fibers, but 
also a considerable number of VIP immunoreactive n rve fibers localized close to 
the acini and surrounding blood vessels (Tsukahara nd Jacobowitz, 1987). 
Finally, the Syrian hamster Harderian gland also contains fl-adrenoceptors, which 
exhibit pronounced sexual differences. Both the receptor number and the 
dissociation constant are higher in females than in males (Pangerl et al., 1989a). 
The aim of this study is to characterize the/3-adrenergic re eptors in the rat 
Harderian gland. We show that [125I]iodocyanopindolol, a/3-adrenergic receptor 
antagonist, is specifically bound by Harderian gland crude membranes, exhibiting 
day-night variations with maximal binding early in the dark period. 
MATERIALS AND METHODS 
Materials 
Bacitracin, bovine serum albumin (BSA), ethylenediaminetetraacetic 
acid (EDTA), N-[2-hydroxyethyl]piperazine-N-[2-hydroxypropanesulfonic acid] 
(HEPES), isoproterenol, propanolol, clonidine, yohimbine, methoxamine, and 
prazosin were purchased from Sigma Chemical Company (St. Louis, MO, USA). 
Phenylmethylsulfonylfluoride (PMSF), N-a-tosyl-L-lysine chloromethyl ketone 
(TLCK), and leupeptin were from Boehringer Mannheim GmbH (Germany). 
[125I]iodocyanopindolol ([125I]CYP; 2200 Ci/mmol) was from Amershaml (Amer- 
sham, UK). 
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Animals and Membrane Preparation 
Adult male Wistar rats born in our animal facility were used. Animals 
received food and water ad libitum and were exposed to an automatically 
regulated light:dark (LD) cycle of 14:10; the lights were turned off daily from 
2000 through 0600 h. On the day of the experiment, animals were killed by 
decapitation and Harderian glands were quickly collected, frozen on solid CO2, 
and stored at -80~ until assayed. 
For membrane preparation, the glands were homogenized using a Polytron 
(2 • I min) in 10 mM Tris-CH1 buffer, pH 7.5, containing 0.25 M sucrose, 0.5 mM 
EDTA, 0.1mg/ml bacitracin, 0.01mg/ml TLCK, 0.01mg/ml eupeptin, and 
0.05 mg/ml PMSF. The homogenate was centrifuged at 16,000 rpm for 30 min at 
4~ The pellet (crude membranes) was washed twice in 20 mM Hepes, pH 7.5, 
and the final pellet was immediately frozen at -80~ until used. Protein 
concentration was determined by using BSA as standard (Lowry et al., 1951). 
Binding of [1251]CYP to Membranes 
For binding reaction, the incubation medium (final volume 0.4 ml) contained 
200/.d of crude membranes, 100/~1 of [125I]CYP and, when required, 100/~1 of 
displacing ligand. For saturation binding studies we used concentrations of 
radioligand between 3 and 1200pM. The incubation was stopped by adding 
10 mM Tris buffer, pH 7.6, (containing 154 mM NaCI, 1 mM MgCI2, and 1 mM 
ascorbic acid), and centrifuged. Then, the radioactivity of the pellet was counted 
in a Beckman gamma-counter. Specific binding was defined as the total binding 
minus the binding measured in the presence of 1/~M of propranolol. The 
equilibrium dissociation constant (Ka) and the maximal number of binding sites 
(Bmax) was calculated from plots according to Scatchard (1949). Data were 
statistically analyzed using an ANOVA, followed by a Student-Newman-Keuls 
multiple range T test. 
RESULTS 
The specific binding of [~25I]CYP to rat Harderian gland membranes was a 
time and temperature-dependent process (Fig. 1). At 30~ the binding of 
[125I]CYP to membranes was rapid, with maximal values at 30 rain and was stable 
until 90 rain. At 0 and 20~ an apparent equilibrium was achieved between 60 
and 90 min, but the maximal binding observed was lesser than that obtained at 
30~ Therefore, it was decided to undertake all subsequent experiments for 
30 min at 30~ 
To determine whether the binding of [125I]CYP was a process dependent on 
the membrane protein concentration, the specific binding of [I~I]CYP was 
studied in the presence of increasing membrane protein concentrations. Figure 2 
shows that binding of [125I]CYP was linearly related to membrane protein 
concentration, at least up to 300~g/ml (r = 0.995). Further incubations were 
performed with 300/zg membrane protein/ml, at 30~ for 30min to provide 
maximal binding. 
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1. Time-course of specific binding of 
[125I]CYP by rat Harderian gland as a function of 
temperature. [125I]CYP (50pM) was incubated 
with rat Harderian gland membranes (300/xg/ml) 
I at 0, 20 and 30~ Specific binding of the tracer was 
30 60 90 determined at the times indicated. Each point is 
the mean of triplicates. Two other experiments 
Time (min) gave similar results. 
Under  opt imal conditions binding of [125I]CYP to rat Harder ian  gland 
membranes  increased during the first 30 min and equi l ibrated after approximately  
30-60min  (Fig. 3, top), with K§ = 1.62. 109M -1 min -1 (Fig. 3, left bottom).  
Fol lowing equil ibrium, binding of [t25I]CYP to Harder ian  gland membranes  was 
reversible. Dissociation of the t racer -membrane complex was studied by the 
addit ion of 1 /xM of propranolol ;  this test indicated a half-t ime of dissociation of 
about  10min,  with K-1 =0.086min  -1 (Fig. 3, right bottom).  The kinetically 
derived value of Ko = 52.0 pM, was obtained f rom the ratio of the rate constants 
(k-1/k§ 
Stoichiometric studies showed that binding of [125I]CYP to rat Harderian 
gland membranes increased with increasing concentrations of radioligand at 
1.2 nM (Fig. 4). Scatchard analysis of the data (Fig. 4, inset) shows binding to a 
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Fig. 2. Specific binding of [125I]CYP by rat Har- 
derian gland membranes as function of protein 
concentration. Increasing concentrations of mem- 
brane protein were incubated with [I251]CYP 
(50 pM) at 0 and 30~ for 30 rain. The specific 
binding was determined and plotted as a function 
of protein concentration. Each point is the mean of 
triplicates. Two other separate xperiments gave 
similar results. 
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Fig. 3. Association and dissociation of [lzSI]CYP 
binding in rat Harderian gland membranes. Top: 
[125I]CYP (50pM) was incubated with crude mem- 
branes (300/zg/ml) at 30~ at the times indicated. 
After 30rnin incubation, 10/xM propranolol was 
added and the specifically bound radioactivity was 
determined at the appropriated times, and expressed 
as the percentage of radioactivity at time zero. Left- 
bottom: Pseudo-first order plot of the association data9 
Bm~ is the specific binding at equilibrium. B is the 
specific binding at the time point measured9 Right- 
bottom: First order plot of the dissociation data 
(r = 09149 Bm,x is the specific binding when dissocia- 
tion is initiated9 
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[12s I]CYP (rkM) 
Saturation isotherm of [12SI]CYP binding to 
rat Harderian gland membranes. Points are the 
means of triplicate determinations, crude mem- 
branes were incubated for 30rain at 30~ Inset: 
Scatchard analysis of binding data indicates a I~ of 
0.29 nM and Bma x of 32 pmol/L. 
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Fig. 5. Competitive displacement of [lzsI]CYP 
binding to rat Harderian gland membranes by 
propranolol. Membranes (300/zg/ml) were in- 
cubated with 50 pM [1251]CYP at 30~ for 30 min 
in the absence or presence of increasing con- 
centration of propranolol. Results are the 
means • SE of 4 separate xperiments performed 
in triplicate. 
single class of binding sites without cooperative interactions. The Ka for the single 
site was 290 pM with a binding capacity of 32 pmol/L. In competition studies, 
results showed that [125I]CYP binding in Harderian gland membranes i highly 
specific for the/3-adrenergic receptors agonists and antagonists. Thus, binding of 
the tracer was inhibited by increasing concentrations of propranolol (Fig. 5). 
Half-maximal inhibition (ICs0) was observed at about 28.1 nM. The specificity of 
/3-adrenoceptors in Harderian gland membranes was also investigated by deter- 
mining the ability of various compounds to compete with the binding of 
[lzsI]CYP. The order of potency of these compounds, as expressed by the IC50 
value, was as follows: isoproterenol (19.1nM), propranolol (28.1nM), and 
norepinephrine (96.3nM). Clonidine, yohimbine, methoxamine, and prazosin 
were ineffective at concentration up to 1/xM (Fig. 6). Thus, binding of [125I]CYP 
to Harderian gland membrane was specific for fl-adrenergic agonists or blockers 
as indicated by the fact that only isoproterenol, propranolol, and nonrepinephrine 
were able to inhibit the binding of the tracer to the membranes. 
Binding [125I]CYP by Harderian gland membranes exhibited day-night 
variations (Fig. 7). Binding values were low during the daytime and increased 
progressively late in the evening to reach a maximum at 2200h; then, binding 
decreased at the end of the dark period (0600 h). 
DISCUSSION 
In the present paper we show that [lzSI]CYP, a ~-adrenergic receptor ligand, 
may interact with rat Harderian gland crude membranes through high-affinity 
binding sites. Binding of [125I]CYP by membranes fulfills all criteria for binding to 
a receptor site. Thus, binding exhibits properties uch as dependence on time and 
temperature as well as reversibility, saturability, high affinity, and specificity. The 
Kd computed from the kinetic analysis agreed to that derived from the saturation 
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Fig. 6. Competitive inhibition of [125I]CYP binding to rat 
Harderian gland membranes by isoproterenol, propranolol, 
methoxamine, prazosin, clonidine and yohimbine. Binding 
is expressed as the percentage of radioactivity specifically 
bound in the absence of drugs. Each point is the mean of 4 
separate xperiments performed in triplicate. 
study, suggesting that the binding followed mass action principles for a pseudo 
first order reaction. 
Saturation studies were performed using exclusively increasing concentra- 
tions of [lZsI]CYP. Interpretation of the data by the Scatchard analysis 
(Scatchard, 1949) disclosed one binding site for the ligand in Harderian gland 
membranes. Values of affinity (Kd = 290 pM) and binding capacity (32 pmol/L) 
15 
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Fig. 7. Day-night variation of [12SI]CYP binding in 
rat Harderian gland. On the day of the experiment, 
animals were killed at the time indicated. The dark 
phase is indicated by the black bar on the time axis. 
Results are the means • SE of 7 animals. 
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are in the same range of those obtained in the Syrian hamster Harderian gland 
(Pangerl et al., 1989a), and in the pineal gland of rat (Gonzalez-Brito etal., 1988) 
and hamster (Pangerl et al., 1989b, 1990); they were also similar to values 
reported using different ligands in other tissues (Dax et aL, 1986; Neve et al., 
1986). With respect to specificity, the greater affinity of the/3-adrenergic agonists 
and blockers compared with other adrenergic agonists has been previously 
demonstrated with different ligands and tissues. 
In this study, binding of [125I]CYP to rat Harderian gland membranes 
exhibited iurnal variations with peak values early in the dark period, and low 
values late at night and during the day. Although stoichiometric studies remain to 
be performed uring the day:night cycle, previous results suggest hat these 
changes in the binding of [IZsI]CYP to membranes are associated to changes in 
the binding capacity rather than to changes in the affinity of the receptor (Pangerl 
et al., 1989a). Our results agree with previous investigations that a diurnal rhythm 
exists in the binding capacity of [I2SI]CYP in the hamster Harderian gland 
(Pangerl et aL, 1989a), and in the pineal gland of the hamster (Pangerl et aL, 
1989b) or the rat (Gonzalez-Brito et al., 1988). 
The physiological role of/3-adrenergic receptor in the rat Harderian gland is 
not well established. However, evidence has been accumulated indicating that 
adrenergic agonists activate the enzyme, type II thyroxine 5'-deiodinase. This 
enzyme has been found in the Harderian gland of rat (Guerrero et al., 1987) and 
hamster (Guerrero et al., 1989) where it is believed to have an important role in 
maintaining intracellular levels of T3 and to serve as a defense against hyroid 
hormone deficiency. Its activity is regulated, not only by the thyroid status, but 
also by both a- and/3-adrenergic agonists (Osuna et al., 1990, 1992; Rubio et aL, 
1991). 
In conclusion, the results presented in this paper show the functional and 
pharmacological characterization f/3-adrenergic receptors in the rat Harderian 
gland. This neurotransmitter may play a physiological role at this level regulating, 
at least, processes such as a thyroid hormone metabolism. 
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